ta 0910 has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A | 1 |
| Cullen, MJ; Dougherty, JP; Gershengorn, MC; Saligan, LN; Wolff, BS | 1 |
| Cullen, MJ; Dougherty, JP; Gershengorn, MC; Springer, DA | 1 |
| Choi, J; Han, PL; Kim, H; Kim, JE; Kim, TK; Lee, EH; Lee, JE; Park, JY | 1 |
| Eto, K; Ishibashi, H; Kim, SK; Nabekura, J | 1 |
| Honda, M; Kimura, S; Nakamura, T; Oda, S; Ono, H; Tanabe, M | 1 |
| Fujitsuka, T; Kinoshita, K; Matsuoka, Y; Yamamura, M | 1 |
| Overstreet, DH | 1 |
| Arrigoni, J; Dement, WC; Kanbayashi, T; Mignot, E; Nishino, S; Shelton, J | 1 |
9 other study(ies) available for ta 0910 and Disease Models, Animal
| Article | Year |
|---|---|
Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Topics: Animals; Ataxia; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Glucose; Male; Mice; Oxazolidinones; Pyrrolidines; Spinocerebellar Degenerations; Thyrotropin-Releasing Hormone | 2020 |
Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Fatigue; Female; Fluorouracil; Gamma Rays; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Nootropic Agents; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 2017 |
Evaluation of the effects of chemotherapy-induced fatigue and pharmacological interventions in multiple mouse behavioral assays.
Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Behavior, Animal; Body Weight; Central Nervous System Stimulants; Disease Models, Animal; Exercise Test; Exploratory Behavior; Fatigue; Female; Fluorouracil; Locomotion; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Swimming; Thyrotropin-Releasing Hormone; Time Factors | 2019 |
TRH and TRH receptor system in the basolateral amygdala mediate stress-induced depression-like behaviors.
Topics: Animals; Basolateral Nuclear Complex; Butadienes; Chronic Disease; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Male; Mice, Inbred C57BL; Nitriles; Psychotropic Drugs; Receptors, Thyrotropin-Releasing Hormone; Restraint, Physical; RNA, Small Interfering; Stress, Psychological; Thyrotropin-Releasing Hormone | 2015 |
Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.
Topics: Adrenergic Agents; Animals; Biogenic Monoamines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Freund's Adjuvant; Gene Expression Regulation; Hyperalgesia; Inflammation; Mice; Nootropic Agents; Oxidopamine; Pain; Pain Measurement; Pain Threshold; Piperazines; Pyridines; Serotonin Antagonists; Thyrotropin-Releasing Hormone | 2011 |
Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.
Topics: Animals; Ataxia; Biogenic Monoamines; Brain Stem; Cerebellum; Disease Models, Animal; Drug Administration Schedule; Mice; Mice, Neurologic Mutants; Nootropic Agents; Spinal Cord; Spinocerebellar Ataxias; Thyrotropin-Releasing Hormone | 2005 |
Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Topics: Administration, Oral; Analysis of Variance; Animals; Ataxia; Cerebellum; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gait; Inferior Colliculi; Male; Mice; Mice, Neurologic Mutants; Pyridines; Rats; Rats, Wistar; Spinal Cord Compression; Thoracic Vertebrae; Thyrotropin-Releasing Hormone | 1995 |
Alternatives to naltrexone in animal models.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Haplorhini; Humans; Naltrexone; Narcotic Antagonists; Rats; Serotonin Antagonists; Serotonin Receptor Agonists; Taurine; Thyrotropin-Releasing Hormone | 1996 |
Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.
Topics: Animals; Cataplexy; Disease Models, Animal; Dogs; Nootropic Agents; Protein Binding; Sleep Stages; Sleep, REM; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1997 |